Fmoc-Sarcosine monohydrate

Fmoc-Sarcosine monohydrate is an N-(9H-fluoren-9-ylmethoxycarbonyl) protected sarcosine derivative in which the amino acid backbone is present as a glycine analog bearing a methylated amide-forming side chain (N-methyl). The molecule contains a stereogenic center at the sarcosine alpha-carbon, and the Fmoc carbamate functions as an acid-labile N-protecting group that supports controlled peptide coupling. A carboxylic acid functionality is present as the amino acid acid form, while the monohydrate indicates defined water association that can influence handling and crystallization behavior. The combination of an Fmoc-protected amine and a free carboxyl group makes the compound a chiral, peptide-compatible intermediate with predictable reactivity under standard protected amino acid synthesis and deprotection conditions.

1. Peptide Synthesis

Fmoc-Sarcosine monohydrate serves as a peptide building block for solid-phase peptide synthesis and solution-phase coupling where controlled N-protection is required for sarcosine incorporation. The Fmoc carbamate masks the alpha-amino group, enabling selective activation of the carboxyl group for amide bond formation while maintaining the N-methyl side-chain as part of the final peptide structure. Side-chain methylation affects local sterics and conformational preferences, which can be used to tune backbone packing and reduce hydrogen-bond donor density in peptide analogs. Deprotection of the Fmoc group generates an N-unprotected sarcosine residue that can be carried through iterative coupling steps to construct peptides and peptidomimetic scaffolds. Downstream, the resulting sarcosine-containing sequences can be used as reference materials for structure-function studies and as synthetic intermediates for further functionalization.

2. Peptidomimetics And SAR Studies

Fmoc-Sarcosine monohydrate is applicable to peptidomimetic construction and structure-activity relationship studies where N-methylation is used to modulate polarity, proteolytic stability, and conformational behavior. The protected amino acid format supports incorporation of a sarcosine unit as a defined, stereochemically consistent fragment into larger molecular scaffolds. The N-methyl side chain can reduce amide hydrogen bonding patterns and influence binding-site interactions when the residue is positioned in a peptide-like framework. Fmoc compatibility supports rapid assembly of residue-defined analog libraries, enabling comparative evaluation of SAR hypotheses driven by side-chain substitution and backbone modifications. The compound thereby functions as a practical chiral intermediate for generating series of sarcosine-modified analogs used in medicinal chemistry research workflows.

3. Chemical Biology Labeling

Fmoc-Sarcosine monohydrate can be used in chemical biology workflows that require incorporation of a sarcosine residue into functional peptides for subsequent conjugation chemistry. The Fmoc-protected amine and carboxylic acid allow the compound to be assembled into peptide backbones while preserving a handle for later derivatization at the peptide level, such as installing linkers or reactive groups through orthogonal side-chain modifications on other residues. The N-methyl feature contributes to altered solubility and reduced backbone amide donor capability, which can be relevant when designing probes for binding assays or imaging reagent development. Controlled removal of the Fmoc group yields a peptide-ready sarcosine unit that can be positioned at N-termini or internal positions depending on the synthetic strategy. The resulting sarcosine-containing constructs can then serve as precursors for biomolecule labeling reagents and for affinity reagents used to interrogate molecular interactions.

4. Protected Amino Acid Chemistry

Fmoc-Sarcosine monohydrate fits protected amino acid synthesis strategies that rely on Fmoc-based orthogonality to manage chemoselective deprotection and peptide coupling. The Fmoc carbamate provides an acid-labile protection element for the alpha-amino group, while the carboxyl group remains available for coupling activation, enabling predictable transformation into amide linkages under standard peptide chemistry conditions. The presence of a defined stereocenter supports stereochemically controlled incorporation of sarcosine into chiral peptide sequences and downstream intermediates. The monohydrate form can be leveraged for reproducible weighing and solid-state handling in manufacturing settings where consistent material behavior is required for scale-up. As a result, the compound can serve as a process chemistry intermediate for preparing sarcosine-containing protected fragments and for building chiral libraries of amino acid derivatives.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-Sarcosine monohydrate is suitable for industrial fine-chemical and pharmaceutical intermediate preparation where Fmoc-protected amino acid building blocks are used to manufacture peptide-based materials. The protected amine and free carboxyl group enable integration into controlled peptide assembly routes, including manufacturing workflows that produce peptide intermediates for further downstream processing into drug-like molecules or research-grade active ingredients. The N-methyl sarcosine residue can be incorporated as a structural element to adjust physicochemical properties such as hydrophobicity balance and amide hydrogen-bonding capacity, which can influence formulation behavior of peptide-derived products. Fmoc deprotection compatibility supports scalable, stepwise synthesis of defined sequences while maintaining stereochemical integrity of the chiral alpha-carbon. The compound therefore functions as a chiral, peptide-compatible intermediate relevant to specialty chemical production and peptide manufacturing supply chains.

1. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

2. High fat diet and GLP-1 drugs induce pancreatic injury in mice

3. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

4. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors